Webcast - Annual Meeting

15-72214-Recently Approved Biomarkers of Acute Kidney Injury (AKI)

  • Duration: 1 hour and 47 minutes
  • Date:JUL.27.2015 2:30 PM - 05:00 PM

Price: $45.00

Member Price: $35.00

Rating: Member Average

This symposium focuses on NephroCheck, a biomarker panel that recently received FDA clearance for identification of acute kidney injury (AKI). The test predicts those who are at risk of developing AKI within 12 hours of the test being performed, allowing for interventions prior to irreversible kidney damage. As opposed to creatinine, which only becomes elevated when 50% of renal function is lost, these biomarkers identify patients in a time frame that allows for implementation of nephron sparing therapies. This symposium covers pathophysiology, clinical utility, and analytical validation of these novel biomarkers.